Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells

Roscovitine and purvalanol are purine derivative cyclin-dependent kinase (CDK) inhibitors that induce apoptosis in various types of cancer cells. However, their impact on the apoptotic cell death mechanism requires further elucidation. Natural polyamines putrescine, spermidine and spermine play essential roles in the regulation of cell growth and proliferation. Increased levels of polyamines in cells are considered to be involved in cancer progression. Intracellular polyamine levels are under the control of several catabolic enzymes, such as spermidine/spermine-N-acetyl transferase (SSAT), acetylpolyamine oxidase (APAO) and spermine oxidase (SMO), which could be altered by several therapeutic drugs. However, the possible role of polyamines in drug-induced apoptosis has yet to be clarified. In the present study, our aim was to determine the modulation of the polyamine catabolic pathway related to CDK inhibitor-induced apoptosis in Caco-2 cells. We found that roscovitine and purvalanol (each 20 μM) induced apoptosis by activating caspase-9 and -3, and inhibiting the mitochondrial membrane potential in Caco-2 cells. CDK inhibitors decreased the intracellular putrescine and spermine levels without affecting spermidine levels. Although both roscovitine and purvalanol induced SSAT expression, they did not exert a significant effect on the APAO expression profile. SSAT transient silencing prevented roscovitine-induced apoptosis compared to parental cells. Thus, we concluded that roscovitine and purvalanol significantly induce apoptosis in Caco-2 cells by modulating the polyamine catabolism, and that SSAT could be an important target in evaluating the potential role of polyamines in apoptotic cell death.

• Publication year

  2012

• Venue

  Molecular Medicine Reports

• Publication date

  2012-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/mmr.2012.768PMID 22294330PMCID 3493106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polyamine depletion enhances the roscovitine-induced apoptosis through the activation of mitochondria in HCT116 colon carcinoma cells

  2011cited by this paper
• The CDK inhibitors in cancer research and therapy

  2011cited by this paper
• Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.

  2011cited by this paper
• Mitotane sensitizes adrenocortical cancer cells to ionizing radiations by involvement of the cyclin B1/CDK complex in G2 arrest and mismatch repair enzymes modulation.

  2010cited by this paper
• VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells

  2010cited by this paper
• Purvalanol A, a CDK inhibitor, effectively suppresses Src‐mediated transformation by inhibiting both CDKs and c‐Src

  2010cited by this paper
• Purvalanol A, a CDK inhibitor, effectively suppresses Src-mediated transformation by inhibiting both CDKs and c-Src

  2010cited by this paper
• Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease

  2010cited by this paper
• Apoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitors.

  2009cited by this paper
• Roscovitine Triggers Apoptosis in B‐Cell Chronic Lymphocytic Leukemia Cells with Similar Efficiency as Combinations of Conventional Purine Analogs with Cyclophosphamide

  2009cited by this paper
• Seliciclib (CYC202, R‐roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model

  2009cited by this paper
• The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer

  2009cited by this paper
• Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor.

  2009cited by this paper
• Polyamine catabolism and disease.

  2009cited by this paper
• Roscovitine Differentially Affects Asynchronously Growing and Synchronized Human MCF‐7 Breast Cancer Cells

  2009cited by this paper
• Different cell cycle kinetic effects of N1,N11-diethylnorspermine-induced polyamine depletion in four human breast cancer cell lines

  2008cited by this paper
• Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.

  2008cited by this paper
• Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells.

  2008cited by this paper
• Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermine

  2008cited by this paper
• Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism

  2008cited by this paper
• Enhancement of radiosensitivity by roscovitine pretreatment in human non-small cell lung cancer A549 cells.

  2008cited by this paper
• Purvalanol A induces apoptosis and downregulation of antiapoptotic proteins through abrogation of phosphorylation of JAK2/STAT3 and RNA polymerase II

  2008cited by this paper
• Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells

  2007cited by this paper
• Purvalanol A Enhances Cell Killing by Inhibiting Up-Regulation of CDC2 Kinase Activity in Tumor Cells Irradiated with High Doses of X Rays

  2007cited by this paper
• The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells

  2007cited by this paper
• Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?

  2006cited by this paper
• Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells.

  2006cited by this paper
• Combination therapy with 2‐difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma

  2006cited by this paper
• Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2.

  2006cited by this paper
• Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation

  2005cited by this paper
• Roscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivo.

  2005cited by this paper
• Spermine Oxidase SMO(PAOh1), Not N1-Acetylpolyamine Oxidase PAO, Is the Primary Source of Cytotoxic H2O2 in Polyamine Analogue-treated Human Breast Cancer Cell Lines*

  2005cited by this paper
• Drugging cell cycle kinases in cancer therapy.

  2005cited by this paper
• Molecular mechanisms of polyamine analogs in cancer cells.

  2005cited by this paper
• Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs.

  2005cited by this paper
• Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells

  1999cited by this paper
• The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.

  1997cited by this paper
• Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells.

  1997cited by this paper
• Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

  1997cited by this paper
• Inhibition of cell growth by accumulated spermine is associated with a transient alteration of cell cycle progression.

  1996cited by this paper
• Polyamines as targets for therapeutic intervention.

  1995cited by this paper
• Directions for polyamine research

  1991cited by this paper
• Interference with S and G2 phase progression by polyamine synthesis inhibitors.

  1978cited by this paper
• Kinetics of cell proliferation and polyamine synthesis during Ehrlich ascites tumor growth.

  1977cited by this paper
• Polyamines as chemical markers of malignancy.

  1976cited by this paper

• Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma

  2024cites this paper
• Indomethacin Induces Spermidine/Spermine-N1-Acetyltransferase-1 via the Nucleolin-CDK1 Axis and Synergizes with the Polyamine Oxidase Inhibitor Methoctramine in Lung Cancer Cells

  2023cites this paper
• Peimine‐induced apoptosis and inhibition of migration by regulating reactive oxygen species‐mediated MAPK/STAT3/NF‐κB and Wnt/β‐catenin signaling pathways in gastric cancer MKN‐45 cells

  2022cites this paper
• Polyamine homeostasis-based strategies for cancer: The role of combination regimens.

  2021cites this paper
• Epibrassinolide-induced autophagy occurs in an Atg5-independent manner due to endoplasmic stress induction in MEF cells

  2020cites this paper
• Biological functions of circular RNAs and their roles in occurrence of reproduction and gynecological diseases.

  2019cites this paper
• Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: Systematic development, characterization and evaluation.

  2017cites this paper
• Application of metabolomics to investigate the antitumor mechanism of flavopiridol in MCF-7 breast cancer cells.

  2016cites this paper
• CDK inhibitors-induced SSAT expression requires NF?B and PPAR? inMCF-7 breast cancer cells

  2015cites this paper
• Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells.

  2014cites this paper
• Epibrassinolide‐induced apoptosis regardless of p53 expression via activating polyamine catabolic machinery, a common target for androgen sensitive and insensitive prostate cancer cells

  2014cites this paper
• CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.

  2014cites this paper
• Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines

  2013cites this paper
• Inhibition of polyamine oxidase prevented cyclin-dependent kinase inhibitor-induced apoptosis in HCT 116 colon carcinoma cells

  2013cites this paper